Kahn, C. R., Vicent, D. & Doria, A. Genetics of non-insulin-dependent (type II) diabetes mellitus. Annu. Rev. Med.47, 509– 531 (1996). ArticleCASPubMed Google Scholar
Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes46, 1–10 ( 1997). Article Google Scholar
Hotamisligil, G. S. The role of TNFα and TNF receptors in obesity and insulin resistance. J. Int. Med.245, 621– 625 (1999). ArticleCAS Google Scholar
Spiegelman, B. M. & Flier, J. S. Adipogenesis and obesity: rounding out the big picture. Cell87, 377–389 (1996). ArticleCASPubMed Google Scholar
Mohamed-Ali, V., Pinkney, J. H. & Coppack, S. W. Adipose tissue as an endocrine and paracrine organ. Int. J. Obes. Relat. Metab. Disord.22, 1145–1158 (1998). ArticleCASPubMed Google Scholar
Friedman, J. M. & Halaas, J. L. Leptin and the regulation of body weight in mammals. Nature395, 763–770 (1998). ArticleADSCASPubMed Google Scholar
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S. & Goldstein, J. L. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature401, 73–76 ( 1999). ArticleADSCASPubMed Google Scholar
Moller, D. E. Potential role of TNFα in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol. Metab.11, 212–217 (2000). ArticleCASPubMed Google Scholar
Lehmann, J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for the nuclear peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem.270, 12953– 12956 (1995). ArticleCASPubMed Google Scholar
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. & Spiegelman, B. M. mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev.8, 1224– 1234 (1994). ArticleCASPubMed Google Scholar
Chawla, A., Schwarz, E. J., Dimaculangan, D. D. & Lazar, M. A. Peroxisome proliferator-activated receptor γ (PPARγ): Adipose predominant expression and induction early in adipocyte differentiation. Endocrinology135, 798–800 (1994). ArticleCASPubMed Google Scholar
Barak, Y. et al. PPARγ is required for placental, cardiac, and adipose tissue development. Mol. Cell4, 585– 595 (1999). ArticleCASPubMed Google Scholar
Rosen, E. D. et al. PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell4, 611–617 (1999). ArticleCASPubMed Google Scholar
Tontonoz, P., Hu, E. & Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell79, 1147–1156 (1994). ArticleCASPubMed Google Scholar
Willson, T. M., Brown, P. J., Sternbach, D. D. & Henke, B. R. The PPARs: from orphan receptors to drug discovery. J. Med. Chem.2000, 527–550 ( 2000). Article Google Scholar
Mukherjee, R. et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature386, 407– 410 (1997). ArticleADSCASPubMed Google Scholar
Barroso, I. et al. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus, and hypertension. Nature402, 880–883 ( 1999). ArticleADSCASPubMed Google Scholar
Kubota, N. et al. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell4, 597 –609 (1999). ArticleCASPubMed Google Scholar
Miles, P. D., Barak, Y., He, W., Evans, R. M. & Olefsky, J. M. Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency. J. Clin. Invest.105, 287–292 (2000). ArticleCASPubMedPubMed Central Google Scholar
Holcomb, I. N. et al. FIZZ1, a novel cysteine-rich secretedprotein associated with pulmonary inflammation, defines a new gene family. EMBO J.19, 4046–4055 (2000). ArticleCASPubMedPubMed Central Google Scholar
Steppan, C. M. et al. A family of tissue-specific resistin-like molecules. Proc. Natl Acad. Sci. USA (in the press).
VanHeek, M. et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J. Clin. Invest.99, 385–390 (1997). ArticleCAS Google Scholar
Ahima, R. S. et al. Role of leptin in the neuroendocrine response to fasting. Nature382, 250–252 (1996). ArticleADSCASPubMed Google Scholar
Seed, B. PPARγ and colorectal carcinoma: conflicts in a nuclear family. Nature Med.4, 1004–1005 (1998). ArticleCASPubMed Google Scholar
Tontonoz, P., Nagy, L., Alvarez, J. G., Thomazy, V. A. & Evans, R. M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell93, 241 –252 (1998). ArticleCASPubMed Google Scholar
Shao, D. & Lazar, M. A. PPARγ, C/EBPα, cell cycle status and the commitment to adipocyte differentiation. J. Biol. Chem.272, 21473–21478 (1997). ArticleCASPubMed Google Scholar
Huang, E. Y. et al. Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. Genes Dev.14, 45–54 ( 2000). CASPubMedPubMed Central Google Scholar
Speicher, D. W. & Reim, D. in Current Protocols in Protein Science (eds Coligan, J. E., Dunn, B. M., Ploegh, H. L., Speicher, D. W. & Wingfield, P. T.) 11.10.11–11.10.38 (John Wiley & Sons, New York, 1997). Google Scholar
Hausdorff, S. F. et al. Identification of wortmannin-sensitive targets in 3T3-L1 adipocytes. J. Biol. Chem.274, 24677– 24684 (1999). ArticleCASPubMed Google Scholar
Nakai, K. & Horton, P. PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem. Sci.24, 34–36 (1999). ArticleCASPubMed Google Scholar
Nielsen, H., Engelbrecht, J., Brunak, S. & von Heijne, G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Engng10, 1–6 (1997). ArticleCAS Google Scholar